GEN-MKT-18-7897-A
Dec 4, 2017 | Blogs, Food / Beverage, Forensic | 0 comments
To date, when it comes to testing urine or oral fluids in the workplace not all psychoactive substances can be detected due to evolving substitutions. As legislation changes, so too do chemical formulations. Therefore researchers, like the authors of the following publication, A Validated Method for the Detection of 32 Bath Salts in Oral Fluids, published by Oxford Academic, analyze compounds using the best available methods so they can cast a wider net.
According to the National Institute on Drug Abuse, synthetic cathinones or bath salts, come from the khat plant in East Africa and Saudi Arabia. People use these drugs by accident or because they are less likely to be detected than drugs such as methamphetamine, MDMA, and cocaine. Which is why the more substances detected, the greater value your forensic lab can bring to workplace drug testing.Access the Publication >
While traditional analysis such as ELISA assays does exist to test for this widely used designer drug, there are limitations which the researchers in the tech note point out. Confirming a drug analysis, however, is critical to the integrity of your lab, and this research note offers a validated method using the SCIEX QTRAP® 6500 operated in electrospray positive mode and MultiQuant™ software. Even if you are not an expert, users can process and quantify large batches of data to get clear, reliable results in the least amount of time using the reporting tool.
Why Should Your Lab Use Mass Spec to Test for Cathinones or Bath Salts?
The Take-AwayMass Spectrometry is the solution to address NPS, from the artificial cannabinoids of the JWH family of compounds found in synthetic cannabis (K2/Spice), phenethylamines (with stimulant, entactogenic or hallucinogenic effects, such as PMMA and 2C-I), tryptamines (which have predominantly hallucinogenic effects, such as AMT and 5-MeO-DALT), piperazines (which exhibit predominantly stimulant effects, such as mCPP and BZP), or cathinones.
Warranty expiration is more than an administrative milestone—it is a transition point that can significantly impact instrument uptime, laboratory productivity, operating budgets, and scientific outcomes.
For more than 20 years, the CDCO has supported academic, commercial, and not‑for‑profit drug discovery programs with deep expertise in pharmaceutical lead optimization. Within the bioanalytical group, their role is to enable rapid and reliable decision‑making through quantitative analysis of candidate drugs in biological matrices.
PFAS are increasingly at the center of regulatory change, scientific research, and industry discussion worldwide. As analytical capabilities improve and expectations around environmental responsibility continue to evolve, understanding the role PFAS play, and how they are being addressed, has never been more important. This blog provides an overview of what PFAS are, why they matter, and how responses from regulators and industry are changing.
Posted by
You must be logged in to post a comment.
Share this post with your network